IP Library Patent Application 10860297
Patent Application
App. No. 10/860,297

Erythrosin-based antimicrobial photodynamic therapy compound and its use

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/860,297
Abstract

A method and composition for destroying microbes, especially bacteria, in the body utilizing Erythrosin B in conjunction with electromagnetic radiation is disclosed. In a preferred method, a composition comprising Erythrosin B is introduced to a treatment area. After a sufficient period of time has elapsed, radiation of a suitable wavelength is applied to the area to activate the Erythrosin B and by a photodynamic reaction to destroy the bacteria. Preferred radiation has a wavelength around 530 nm. Erythrosin B is incorporated within a gel, which acts to restrict the photodynamic action proximate to the biofilm, thus ensuring that only unwanted bacteria is effected and natural microflora is unharmed. This method is effective for destroying at least Gram-positive bacteria, and is particularly effective in areas where complex media such as saliva are also present.

Claims (26)

1 . A method of destroying bacteria in a treatment area of a patient comprising the steps of:

a. introducing a composition comprising Erythrosin B as a photosensitizer in a gel to a treatment area on a biological surface;

b. allowing a predetermined time period to elapse to allow said Erythrosin B to couple with bacteria in said treatment area;

c. applying radiation of a preselected wavelength to said treatment area to activate said Erythrosin B and thus stimulating a photodynamic reaction to destroy said bacteria; and

wherein complex media is present in said treatment area.

2 . The method of destroying bacteria according to claim 1 , wherein said complex media is saliva.

3 . The method of destroying bacteria according to claim 1 , wherein said treatment area is bacterial plaque on areas selected from the group consisting of teeth and tongue dorsa.

4 . The method of destroying bacteria according to claim 1 , wherein said treatment area is dental caries.

5 . The method of destroying bacteria according to claim 1 , wherein said preselected wavelength is between about 500 nm and about 580 nm.

6 . The method of destroying bacteria according to claim 1 , wherein said preselected wavelength is about 530 nm.

7 . The method of destroying bacteria according to claim 1 , wherein a concentration of said Erythrosin B in said composition is greater than 1 mM per 0.5 ml of said composition.

8 . The method of destroying bacteria according to claim 1 , wherein a concentration of said Erythrosin B in said composition is 8 mM per 0.5 ml of said composition.

9 . The method of destroying bacteria according to claim 1 , wherein said predetermined time period is at least 1 minute.

10 . The method of destroying bacteria according to claim 9 , wherein said predetermined time period is between 3 minutes and 5 minutes.

11 . The method of destroying bacteria according to claim 9 , wherein said predetermined time period is at least 5 minutes.

12 . The method of destroying bacteria according to claim 1 , wherein said applying radiation step is accomplished by a non-coherent lamp.

13 . The method of destroying bacteria according to claim 1 , wherein said radiation application step is accomplished by an optical transmission system coupled to a radiation source.

14 . The method of destroying bacteria according to claim 13 , wherein said optical transmission system is at least one optical fiber.

15 . The method for destroying bacteria according to claim 1 , wherein said radiation is selected from the group consisting of non-coherent radiation and coherent laser radiation.

16 . The method of destroying bacteria according to claim 1 , wherein said radiation is applied at a fluence rate is at least about 0.05 W/cm 2 .

17 . The method of destroying bacteria according to claim 16 , wherein said fluence rate is between about 0.3 W/cm 2 and about 0.5 W/cm 2 .

18 . The method of destroying bacteria according to claim 16 , wherein a duration of said application of said radiation is about 3 minutes.

19 . The method for destroying bacteria according to claim 1 , wherein said treatment area is selected from the group consisting of teeth and gums.

20 . The method for destroying bacteria according to claim 1 , wherein said composition further comprises a material selected from the group consisting of hydroxyethyl cellulose and propyleneglycol.

21 . An anti-microbial photodynamic therapy composition for treatment of biological surfaces comprising Erythrosin B and a gel containing a component for solubilizing said Erythrosin B.

22 . The anti-microbial photodynamic therapy composition according to claim 21 , further comprising a material selected from the group consisting of hydroxyethyl cellulose and propyleneglycol.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2016
From: BIOLITEC PHARMA MARKETING LTD.
To: BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG
Reel/Frame 041182/0578 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2009
From: BIOLITEC, INC.
To: BIOLITEC PHARMA MARKETING LTD.
Reel/Frame 022482/0944 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2009
From: CERAMOPTEC INDUSTRIES, INC.
To: BIOLITEC, INC.
Reel/Frame 022482/0956 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2004
From: ALBRECHT, VOLKER; GITTER, BURKHARD
To: CERAMOPTEC INDUSTRIES, INC.
Reel/Frame 015440/0978 →